CD4 and immune system disorder: The HIV-1 Vpr could be produced and released from HIV-1 sequestered tissue reservoirs during cART treatment (62, 63), and Vpr has been shown to participate in the HIV-mediated immune dysfunction and CD4+ T-cell depletion (64–69).